Boston Trust Walden Corp Edwards Lifesciences Corp Transaction History

Boston Trust Walden Corp

$14 Billion
Q4 2024

A detailed history of Boston Trust Walden Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Boston Trust Walden Corp holds 282,372 shares of EW stock, worth $19.5 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

282,372

Previous 149,743 88.57%

Holding current value

$19.5 Million

Previous $9.88 Million 111.55%

% of portfolio

0.15%

Previous 0.07%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	BUY	$64.54 - $75.92 $8.56 Million - $10.1 Million	132,629 Added 88.57%	282,372 $20.9 Million
Q3 2024 Oct 24, 2024	BUY	$59.7 - $93.78 $2,388 - $3,751	40 Added 0.03%	149,743 $9.88 Million
Q4 2023 Jan 24, 2024	SELL	$61.71 - $77.76 $136,502 - $172,005	-2,212 Reduced 1.46%	149,703 $11.4 Million
Q3 2023 Oct 18, 2023	SELL	$69.28 - $93.38 $48,496 - $65,366	-700 Reduced 0.46%	151,915 $10.5 Million
Q2 2023 Jul 24, 2023	SELL	$81.41 - $94.33 $90,446 - $104,800	-1,111 Reduced 0.72%	152,615 $14.4 Million
Q1 2023 Apr 19, 2023	SELL	$74.26 - $84.51 $66,091 - $75,213	-890 Reduced 0.58%	153,726 $12.7 Million
Q4 2022 Jan 20, 2023	SELL	$68.3 - $87.44 $50,268 - $64,355	-736 Reduced 0.47%	154,616 $0
Q3 2022 Oct 19, 2022	SELL	$82.37 - $107.29 $901,127 - $1.17 Million	-10,940 Reduced 6.58%	155,352 $12.8 Million
Q2 2022 Jul 22, 2022	SELL	$86.5 - $128.27 $45,499 - $67,470	-526 Reduced 0.32%	166,292 $15.8 Million
Q1 2022 Apr 20, 2022	SELL	$101.96 - $128.34 $1.79 Million - $2.25 Million	-17,510 Reduced 9.5%	166,818 $19.6 Million
Q4 2021 Jan 21, 2022	SELL	$106.37 - $130.68 $531,850 - $653,400	-5,000 Reduced 2.64%	184,328 $23.9 Million
Q3 2021 Oct 25, 2021	BUY	$102.91 - $122.75 $84,283 - $100,532	819 Added 0.43%	189,328 $21.4 Million
Q2 2021 Jul 22, 2021	SELL	$83.84 - $104.76 $603,648 - $754,272	-7,200 Reduced 3.68%	188,509 $19.5 Million
Q1 2021 Apr 21, 2021	SELL	$78.68 - $90.67 $1.53 Million - $1.76 Million	-19,445 Reduced 9.04%	195,709 $16.4 Million
Q4 2020 Jan 15, 2021	SELL	$71.69 - $91.23 $57,352 - $72,984	-800 Reduced 0.37%	215,154 $19.6 Million
Q3 2020 Oct 14, 2020	SELL	$67.19 - $87.44 $53,886 - $70,126	-802 Reduced 0.37%	215,954 $17.2 Million
Q2 2020 Jul 23, 2020	BUY	$57.54 - $76.95 $8.18 Million - $10.9 Million	142,079 Added 190.26%	216,756 $15 Million
Q1 2020 Apr 21, 2020	SELL	$52.41 - $81.0 $407,120 - $629,208	-7,768 Reduced 9.42%	74,677 $14.1 Million
Q4 2019 Jan 10, 2020	SELL	$71.7 - $82.09 $13,694 - $15,679	-191 Reduced 0.23%	82,445 $19.2 Million
Q3 2019 Oct 21, 2019	SELL	$61.55 - $75.43 $43,085 - $52,801	-700 Reduced 0.84%	82,636 $18.2 Million
Q2 2019 Jul 25, 2019	SELL	$55.74 - $64.41 $12,875 - $14,878	-231 Reduced 0.28%	83,336 $15.4 Million
Q4 2018 Jan 17, 2019	SELL	$46.41 - $56.94 $181,741 - $222,977	-3,916 Reduced 4.48%	83,567 $12.8 Million
Q2 2018 Jul 25, 2018	SELL	$42.45 - $51.3 $26,319 - $31,806	-620 Reduced 0.7%	87,483 $12.7 Million
Q1 2018 Apr 13, 2018	SELL	$37.19 - $47.45 $193,388 - $246,740	-5,200 Reduced 5.57%	88,103 $12.3 Million
Q4 2017 Jan 29, 2018	SELL	$33.79 - $39.39 $28,620 - $33,363	-847 Reduced 0.9%	93,303 $10.5 Million
Q3 2017 Oct 13, 2017	BUY	$36.29 - $38.83 $3.42 Million - $3.66 Million	94,150	94,150 $10.3 Million

Others Institutions Holding EW

# of Institutions

1,352

Shares Held

469M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $42.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account

Boston Trust Walden Corp Edwards Lifesciences Corp Transaction History